Bone cancer, or a malignant tumor that actually starts in the bone, is a very rare form of cancer. When this does occur, it’s called primary bone cancer. But other types of cancer can affect the bones as well. When cancer begins in the lungs, breasts or other parts of the body and then spreads to the bones, this is known as metastatic cancer. There are also cancers that begin in the blood-producing cells of the bone, known as the bone marrow. These include multiple myeloma, leukemia and some lymphomas. But here again, these types of cancers are usually not referred to as "bone cancer."
If a cancer that is truly defined as bone cancer is present, it can affect any of the cells of the bones. The types of cancer most often found are osteosarcoma, which affects tissue known as osteoid; chondrosarcoma, which affects cartilage; and the Ewing sarcoma family of tumors, a group of cancers that often infect the soft tissue around the bones as well as the bones themselves.
In many cases, bone cancer may exhibit no symptoms. If bone cancer does present symptoms, the primary one is pain emanating from the bones. This pain can increase as the cancer progresses.
Causes of Bone Cancer
Bone cancer may be caused by genetic mutations. Other risk factors for developing bone cancer include age and smoking, though some people with no risk factors can also develop bone cancer.
Treatment
The most common treatment for a bone cancer is surgery to remove the tumor. Surgical procedures have improved enough over the years that this can usually be done without the patient losing an entire limb. However, some type of reconstruction surgery may be necessary after the surgery to restore the bone to full function. After surgery, follow-up treatments of radiation, chemotherapy or cryosurgery may be required to rid the body of cancerous cells.
SOURCES: U.S. National Cancer Institute; American Cancer Society
But the gene flaw is rare, affecting less than 1 percent of typical cancers, researchers say
Extra chemo drugs failed to change course of osteosarcoma, researchers say
Discoveries challenge belief that it is a modern-day disease
FDA-approved drugs to be tested on canines with bone cancer that also affects humans
Doctors note advances in therapies have boosted survival rates
Study looked at method for blocking key growth protein in malignant nerve sheath tumors
British researchers followed more than 100,000 children for 17 years
Just one session is needed for effective pain relief, but many men get 10, according to researcher
Discovery sheds light on history of tumors in humans, researchers say
Cases of prostate, thyroid, multiple myeloma cancers seen over years
But expert says it's too soon to say it will replace older drug
Jakafi won't cure myelofibrosis, but it improves quality of life, studies find
Research in canines may lead to tests that can predict aggressiveness of disease in humans
People taking Fosamax, other bisphosphonates had lowered odds compared to non-users, study found
Blocks protein that destroys bone cells
Life expectancy is reduced by 10 years on average, study finds
First reported case where procedure led to natural second pregnancy
Study finds no bleeding risk in practice that could stretch limited supplies
Bisphosphonates seem to prevent recurrence, researchers find
Experimental drug may lead to therapy that inhibits metastasis, research suggests
Lower dose of standard medication leads to better outcome, researchers say
It doesn't affect quality of life in most cases, review finds
Reasons for racial disparity remain unclear, researcher says
Italian researchers report bedridden patients walked 24 hours after treatment
Zometa, used to treat osteoporosis, showed no unanticipated side effects, researchers report
Finding could yield first targeted therapy for the rare disease, researchers say
Researchers look to engineer the virus as treatment for multiple myeloma
Researchers urge further investigation into targeted therapies to improve survival rate
They were nine times more likely to develop secondary malignancy, study finds
But the benefits of growth factors may outweigh the concerns, experts say
Study finds therapy produces significant gains against blood, bone marrow cancers
BRCA2 mutations up risks for other malignancies, study finds
Finding could one day help doctors better tailor therapy for patients, study says
Freezing or heating tumors kills the cancer and the pain
Online appeal to patients helps ID bone marrow cancer gene
But mouse study doesn't prove treatment works in women
Study results may help find new treatment for incurable cancer
High-energy radio-isotope slows bone metastases, researchers found
Expert panel recommends it over standard chemotherapy
Once controversial drug may help delay progression of cancer for up to two years
Reconstructed hip working well, Italians report
Latest research finds more potent drug stems bone marrow cancer
Gleevec shows promise against bone tumor